A study to assess incidence of severe SARS-CoV-2 infections occurrence in vaccinated kidney transplant and haemodialysis patients
Latest Information Update: 02 Aug 2022
At a glance
- Drugs Elasomeran (Primary) ; Tozinameran (Primary)
- Indications COVID 2019 infections
- Focus Therapeutic Use
Most Recent Events
- 08 Jun 2022 Results presented at the 2022 American Transplant Congress
- 27 Apr 2022 New trial record
- 01 Apr 2022 Results published in the Journal of Nephrology